wow, looks like it's put up or shut up time, page-7

Hi Blokes,

Thank you for sending that video. There was another that Isonea released with the conference he attended. Also worth watching if you haven't already.

After a frustrating year - they were finally forthright in their schedule (airsonea - categorically will be released this year) and marketing around getting airsonea to market.... There is a critical amount of detail they needed to release in order to engender buy in, and clearly the market responded today accordingly.

Still, the stock is highly illiquid and the short term share price is irrelevant; either they deliver Airsonea this year, in which case the company is worth something - or they wont in which case it will be worth nothing.

I note the comment on a bulk sale to insurers. There's a much bigger focus on preventative medicine in the States. When I lived there, my insurer paid for me to have an annual check-up (medical and dental) which included full bloodwork - the whole nine. The logic being it's obviously cheaper to fix you sooner. (I asked my GP when I returned when to schedule a check up and they laughed....) Anyways, that line of thinking - that insurers might get on board with this somehow - is quite valid over there......

I note the potential key risk of FDA approval was not addressed. Still unclear if that might impact Airsonea. I might write MT an email asking him to clarify.......